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Educational aims
●● To review the cross-sectional imaging appearance of bronchiectasis and the common associated 
findings.
●● To get a sense of how radiology can aid in establishing the aetiology of bronchiectasis.
Key points
●● Bronchiectasis is a chronic progressive condition with significant disease burden and frequent 
exacerbations, for which the diagnosis relies on cross-sectional imaging.
●● The major imaging findings include bronchial dilatation, bronchial contour abnormalities and 
visualisation of the normally invisible peripheral airways.
●● Bronchiectasis is the end result of various conditions, including immunodeficiencies, mucociliary 
disorders and infections. Imaging is often nonspecific with regard to aetiology but can be suggestive.
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Bronchiectasis is a chronic progressive condition with significant disease burden and frequent 
exacerbations for which the diagnosis relies on cross-sectional imaging http://bit.ly/2NxOLky
Radiology plays a key role in the diagnosis of bronchiectasis, defined as permanent dilatation of 
the bronchial lumen. Volumetric thin-section multidetector computed tomography is an excellent 
noninvasive modality to evaluate bronchiectasis. Bronchiectasis is categorised by morphological 
appearance. Cylindrical bronchiectasis has a smooth tubular configuration and is the most common 
form. Varicose bronchiectasis has irregular contours with alternating dilating and contracting 
lumen. Cystic bronchiectasis is the most severe form and exhibits saccular dilatation of bronchi. 
Bronchial dilatation is the hallmark of bronchiectasis and is evaluated in relation to the accompanying 
pulmonary artery. A broncho–arterial ratio exceeding 1:1 should be considered abnormal. Normal 
bronchi are narrower in diameter the further they are from the lung hila. Lack of normal bronchial 
tapering over 2 cm in length, distal from an airway bifurcation, is the most sensitive sign of 
bronchiectasis. Findings commonly associated with bronchiectasis include bronchial wall thickening, 
mucus plugging and tree-in-bud opacities. Bronchiectasis results from a myriad of conditions, 
with post-infectious bronchiectasis being the most common. Imaging can sometimes discern the 
cause of bronchiectasis. However, in most cases it is nonspecific or only suggestive of aetiology. 
While morphological types are nonspecific, the distribution of abnormality offers clues to aetiology.
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Introduction
Diagnostic imaging plays a key role in the diagnosis 
of bronchiectasis, defined as permanent dilatation 
of the bronchial lumen. Bronchiectasis is increasing 
in incidence and frequently encountered on 
imaging [1]. Bronchiectasis carries significant 
disease burden, with reduction in health-related 
quality of life and frequent exacerbations often 
requiring inpatient management, and it is associated 
with increased mortality [2]. Its pathogenesis is 
thought to result from an initial insult to the airway 
followed by a vicious cycle of repeated infection and 
ineffective mucociliary clearance. Disruption of the 
peribronchial interstitial scaffolding and outward 
traction is thought to be its pathogenesis in relation 
to fibrotic lung disease. Bronchiectasis is classically 
categorised by morphological appearance [3]. 
Cylindrical bronchiectasis has a smooth tubular 
configuration and is the most common form. 
Varicose bronchiectasis is often seen with fibrosis 
and has irregular contours with alternating dilating 
and contracting lumen. Cystic bronchiectasis 
is the most severe form and exhibits saccular 
dilatation of bronchi, often with air–fluid levels. 
Volumetric thin-section multidetector computed 
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tomography (CT) is an excellent noninvasive 
modality to evaluate bronchiectasis and allows 
for contiguous millimetre image reconstructions, 
multiplanar reformations and minimal intensity 
projections [4].
In this concise pictorial review, we revisit the 
imaging hallmarks of bronchiectasis and associated 
imaging findings, along with pitfalls and clues to 
common aetiologies for the respiratory clinician. We 
limit the review to non-cystic fibrosis bronchiectasis 
in adults, with a focus on bronchiectasis in non-
fibrotic lung disease.
Imaging findings
The diagnostic imaging findings in bronchiectasis 
are summarised in table 1. Bronchial dilatation is 
the hallmark of bronchiectasis and is evaluated in 
relation to the accompanying pulmonary artery 
(figure 1a). In practical terms, a broncho–arterial 
ratio exceeding 1:1 should be considered abnormal. 
Numerous physiological and disease-related 
conditions may affect the ratio and a cut-off of 
>1.3:1 or 1.5:1 results in increased specificity 
[5, 6]. Examples of other common causes of 
dilated bronchi and how to differentiate these 
from bronchiectasis are presented in table 2. 
Mild bronchial dilation can, for instance, be seen 
in high-altitude habitation and normal ageing. 
Pulmonary artery diameter can also be affected by 
vasoconstriction and pulmonary hypertension [6]. 
An important pitfall with the finding of bronchial 
dilatation is that mild reversible bronchial dilatation 
can be associated with atelectasis or inflammation, 
such as infectious pneumonia. This may be difficult 
to distinguish from true bronchiectasis, which is 
permanent, and precaution should be used in 
patients with signs of infection (figure 2).
Normal bronchi are narrower in diameter the 
further they are from the lung hila. Lack of normal 
bronchial tapering over 2 cm in length, distal from 
a) b) c)
#
Figure 1 Imaging findings in bronchiectasis. a) The arrow points to cylindrical bronchiectasis in the right lower lobe. The bronchi are dilated in relation to 
the pulmonary artery, producing a signet ring sign. There are also visible airways in the subpleural 1 cm of lung, demarcated by the dashed line. Airways are 
normally not visible peripherally and when seen are indicative of bronchiolectasis. b) Curved planar reformation shows lack of bronchial tapering in the right 
lower lung, in keeping with cylindrical bronchiectasis (arrow). This is the earliest and most sensitive sign of bronchiectasis. The aetiology of bronchiectasis in this 
patient was bronchiolitis obliterans after allogeneic haematopoietic stem cell transplantation. c) Different morphological types of bronchiectasis are often seen 
in the same patient. This patient had cylindrical bronchiectasis (arrow) with lack of bronchial tapering in the right lower lobe and varicose bronchiectasis in the 
right middle lobe (arrowhead). Tree-in-bud opacities, a common associated finding, are also noted (#).
Table 1 Diagnostic imaging findings in bronchiectasis
Imaging findings in bronchiectasis
Bronchial dilatation: objectively assessed by broncho–arterial ratio >1:1 (or >1.5:1 for increased 
specificity)
Lack of bronchial tapering >2 cm in length from airway bifurcation
Visible peripheral airways within 1 cm vicinity of costal pleura or directly abutting mediastinal pleura
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an airway bifurcation, is the most sensitive sign of 
bronchiectasis and is helpful in evaluating subtle 
cylindrical bronchiectasis (figure 1b) [7]. Visible 
airways in the 1-cm vicinity of costal subpleural lung 
are another useful sign of bronchiectasis (figure 1a). 
Airways are normally not visible peripherally in the 
lung and when visible are suggestive of dilatation 
of the non-cartilage-containing small airways, 
i.e. bronchiolectasis. Visible airways in the 1-cm 
vicinity of mediastinal subpleural lung are seen in 
many patients with bronchiectasis but also in a 
significant number of normal subjects and should, 
therefore, be considered a sign of bronchiectasis 
only when directly abutting the mediastinal pleural 
surface [8].
Findings commonly associated with bronchi-
ectasis include bronchial wall thickening, mucus 
plugging and tree-in-bud opacities (figure 1c and 
table 1). These findings serve as indirect signs and 
can increase the radiologist’s confidence in diag-
nosing mild bronchiectasis. Bronchial wall thicken-
ing is a potentially reversible finding and correlates 
with patient-reported symptoms, health status and 
 frequency of exacerbation [9–11]. This finding, 
often subjectively evaluated, usually represents 
airway inflammation and can be seen in asthma 
and bronchitis but is also occasionally observed in 
normal individuals [5]. Tree-in-bud opacities rep-
resent mucus plugging or inflammatory material 
within the bronchioles at the level of the secondary 
pulmonary lobule and are usually a sign of endo-
bronchial infection.
Common causes and 
imaging clues to aetiology
Bronchiectasis can result from a myriad of 
conditions, including immunodeficiencies, 
mucociliary disorders and infections, with 
post-infectious bronchiectasis being the most 
common [12]. Despite thorough diagnostic workup, 
the cause in many cases remains unknown [2]. 
Imaging can sometimes discern the cause of 
bronchiectasis, such as in the case of foreign 
bodies, obstructing tumours or post-radiation 
fibrosis (figure 3). However, in most cases it 
is nonspecific or only suggestive of aetiology. 
Morphological types are mostly nonspecific. 
Distribution of abnormalities, however, offers 
clues to aetiology. Upper lobe predominance 
is seen in cystic fibrosis, sarcoidosis (figure 4a), 
post-tuberculous scarring (figure 4b) and post-
radiation fibrosis (figure 3). Calcified hilar or 
mediastinal lymph nodes and calcified pulmonary 
granulomas suggest granulomatous infection, such 
as tuberculosis. Anterior segment distribution 
(middle lobe and lingula) is typically seen in 
atypical mycobacterial infection, which often 
affects middle-aged or elderly female patients 
(figure 4c). Mycobacterium avium–intracellulare 
complex (MAC) infections usually affect two or more 
lobes, often with scarring and a few small nodules 
up to 1 cm in size. Consolidation and cavitation 
may also be a feature (figure 4d). Lower lobe 
distribution is most often seen in post-infectious 
bronchiectasis, chronic aspiration (figure 5), 
immunodeficiencies (figure 6a) and primary ciliary 
a) b)
Figure 2 An important pitfall: mild reversible bronchial dilatation due to infection. This 
patient’s clinical presentation gave concern for lower respiratory infection. a) Initial CT demon-
strated bronchial dilatation with bronchial wall thickening (arrows) and areas of air space 
opacification (arrowhead), in keeping with bronchopneumonia. b) Subsequent imaging after 
antibiotic treatment revealed resolution of the air space opacification and a return of the bronchi 
to normal calibre. This does not reflect true bronchiectasis, which is irreversible.
Table 2 Examples of other common causes of dilated bronchi
Other causes of dilated bronchi How to differentiate from bronchiectasis
Normal ageing
High altitude
Clinical context is key
Bronchial dilatation tends to be generalised and mild (broncho–arterial ratio <1.5:1)
No associated imaging findings of airway disease or inflammation
Regional hypoxia Bronchial dilatation usually mild
Bronchi may actually be normal in diameter but have increased broncho–arterial ratio due to 
small pulmonary artery secondary to hypoxic vasoconstriction
Bronchopneumonia Acute clinical symptoms
Comparison to prior studies
May require re-imaging
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dyskinesia (figure 6b). Allergic bronchopulmonary 
aspergillosis (ABPA) bears mention due to the 
characteristic imaging appearance and need for 
specific medical management (figure 7). This 
condition is caused by a hypersensitivity reaction 
to endobronchial Aspergillus and imaging typically 
demonstrates central bronchiectasis with extensive 
mucus plugging, which in up to a fifth of cases is 
characteristically high attenuating (>70–100 HU) 
and is thought to be due to iron and manganese 
accumulation in the fungal debris. Location of 
bronchiectasis can have treatment implications 
in some cases, as focal bronchiectasis may be 
considered for lobectomy or segmentectomy, 






Figure 4 a) Varicose bronchiectasis (arrow) in a patient with sarcoidosis. Note the typical upper lobe location and associ-
ated reticulation and lung architectural distortion (#), suggesting fibrosis. b) Post-tuberculous bronchiectasis in a 90-year-
old patient with a previous history of tuberculosis. The apical unilateral distribution is typical. c) Bronchiectasis in the right 
middle lobe and lingula in a 50-year-old female patient with a MAC infection. The anterior lung segment involvement is 
typical. d) Bronchiectasis in a different elderly female patient with severe MAC infection. Bilateral cylindrical bronchiectasis 
is noted as well as nodules (arrowhead), some of which have benign pattern central calcification. Consolidation with cavi-




Figure 3 Post-radiation fibrosis. a) This patient had non-small cell lung cancer in the right lower lobe (not shown). The 
arrows show ground-glass opacities arising after radiation therapy, representing radiation pneumonitis. b) 4 months later 
there was interval development of post-radiation fibrosis with varicose bronchiectasis and volume loss in the treatment 
field (#).
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Figure 5 a) An 88-year-old female patient with chronic obstructive pulmonary disease (COPD), dysphagia and frequent 
lower respiratory infections. The arrow points to aspirated contrast material in the trachea. b) CT in the same patient 
shows bilateral lower zone bronchiectasis (arrowheads) and tree-in-bud opacities (#). The presumed aetiology was chronic 
aspiration.
a) b)
Figure 6 a) Bronchiectasis in immunodeficiency. This patient had hyperimmunoglobulin E syndrome (Job’s syndrome) and 
extensive bronchiectasis in the right lower lobe complicated by consolidation and an abscess formation (arrow). b) Ancillary 
findings with bronchiectasis. This patient had primary ciliary dyskinesia with widespread mucus plugging and adjacent 
consolidation, suggesting infection in the right lower lobe and middle lobe (arrowheads). The arrow points to bronchial wall 
thickening. Note the situs inversus.
a) b)
Figure 7 A 71-year-old male with a history of asthma presented with a 3-month history of productive cough. This patient 
had a positive sputum culture for Aspergillus and peripheral blood eosinophilia. Skin-prick test was positive for Aspergillus 
and serum IgE levels, including Aspergillus-specific IgE levels, were markedly elevated. a) Non-contrast-enhanced CT 
shows high-attenuation mucus plugging (>70 HU) within dilated central airways (arrow) and atelectasis typical for ABPA. 
b) Follow-up imaging after antifungal and steroid treatment revealed resolution of the mucus plugging and atelectasis with 
residual cylindrical bronchiectasis (arrow).
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Complications
Bronchiectasis is a chronic progressive disease 
characterised by acute respiratory infections. 
Chronic airway inflammation promotes neovas-
cularisation and arterial remodelling, resulting 
in fragile vessels that are prone to bleeding. This 
can cause haemoptysis, which is sometimes the 
presenting symptom in bronchiectasis and less 
commonly results in massive haemoptysis, requir-
ing surgical intervention or therapeutic catheter 
angiography (figure 8a and b). Massive haemopty-
sis is due to bleeding from the bronchial arteries in 
the majority of cases (figure 8c) and less commonly 
from pulmonary arteries or non-bronchial systemic 
arteries [14].
Conclusion
Bronchiectasis is a common finding on CT 
examinations of the chest. It is defined as 
permanent dilatation of the bronchial lumen, thus 
requiring radiological imaging for diagnosis. The 
condition carries significant disease burden, which 
makes it important for radiologists and clinicians to 
have detailed knowledge of its imaging appearance 
and associated findings, as well as findings that may 
aid in establishing aetiology.
Affiliations
Gunnar Juliusson1, Gunnar Gudmundsson2,3
1Dept of Radiology, Landspitali University Hospital, Reykjavik, Iceland. 2Dept of Respiratory Medicine, Landspitali 




Funding was received from the Landspitali Research Fund (A-2018-023).
References
 1. Quint JK, Millett ER, Joshi M, et al. Changes in the incidence, 
prevalence and mortality of bronchiectasis in the UK from 
2004 to 2013: a population-based cohort study. Eur Respir J 
2016; 47: 186–193.
 2. McShane PJ, Naureckas ET, Tino G, et al. Non-cystic fibrosis 
bronchiectasis. Am J Respir Crit Care Med 2013; 188: 647–656.
 3. Reid LM. Reduction in bronchial subdivision in bronchiectasis. 
Thorax 1950; 5: 233–247.
a) b) c)
Figure 8 a) CT pulmonary angiogram of a 70-year-old patient with Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage four COPD on long-
term oxygen therapy presenting with massive haemoptysis. Magnified sagittal reformation shows focal contour abnormality of a subsegmental pulmonary artery 
in keeping with a pseudoaneurysm associated with cylindrical bronchiectasis (arrowhead). The arrow points to adjacent air space opacities representing alveolar 
blood. b) Volume-rendered image of the pseudoaneurysm. The bleeding resolved with medical treatment and the pseudoaneurysm, bronchial wall thickening 
and air space opacities resolved on follow-up imaging. Case courtesy of Agusta Andresdottir (Landspitali University Hospital, Reykjavik, Iceland). c) Enlarged 
(>2 mm diameter) and tortuous bronchial arteries (arrow) in a different patient with severe bilateral bronchiectasis. This finding is not specific to bronchiectasis 
and is seen in disorders affecting the pulmonary circulation, and chronic infectious or inflammatory disease, as well as congenital conditions.
Breathe | September 2019 | Volume 15 | No 3 197
Diagnostic imaging in adult non-cystic fibrosis bronchiectasis
 4. Bonavita J, Naidich DP. Imaging of bronchiectasis. Clin Chest 
Med 2012; 33: 233–248.
 5. Lynch DA, Newell JD, Tschomper BA, et al. Uncomplicated asthma 
in adults: comparison of CT appearance of the lungs in asthmatic 
and healthy subjects. Radiology 1993; 188: 829–833.
 6. Milliron B, Henry TS, Veeraraghavan S, et al. Bronchiectasis: 
mechanisms and imaging clues of associated common and 
uncommon diseases. Radiographics 2015; 35: 1011–1030.
 7. Kang EY, Miller RR, Müller NL. Bronchiectasis: comparison 
of preoperative thin-section CT and pathologic findings in 
resected specimens. Radiology 1995; 195: 649–654.
 8. Kim JS, Müller NL, Park CS, et al. Cylindrical bronchiectasis: 
diagnostic findings on thin-section CT. AJR Am J Roentgenol 
1997; 168: 751–754.
 9. Tan WC, Hague CJ, Leipsic J, et al. Findings on thoracic 
computed tomography scans and respiratory outcomes in 
persons with and without chronic obstructive pulmonary 
disease: a population-based cohort study. PLoS One 2016; 
11: e0166745.
 10. Lynch DA, Newell J, Hale V, et al. Correlation of CT 
findings with clinical evaluations in 261 patients with 
symptomatic bronchiectasis. AJR Am J Roentgenol 1999; 173: 
53–58.
 11. Ooi GC, Khong PL, Chan-Yeung M, et al. High-resolution 
CT quantification of bronchiectasis: clinical and functional 
correlation. Radiology 2002; 225: 663–672.
 12. King PT. The pathophysiology of bronchiectasis. Int J Chron 
Obstruct Pulmon Dis 2009; 4: 411–419.
 13. Gudbjartsson T, Gudmundsson G. Middle lobe syndrome: 
a review of clinicopathological features, diagnosis and 
treatment. Respiration 2012; 84: 80–86.
 14. Larici AR, Franchi P, Occhipinti M, et al. Diagnosis and 
management of hemoptysis. Diagn Interv Radiol 2014; 20: 
299–309.
